Efforts Towards Polio Eradication in Madagascar: 1997 to 2017.

Marcellin Mengouo Nimpa, Noёline Ravelomanana Razafiarivao, Annick Robinson, Mamy Randriatsarafara Fidiniaina, Richter Razafindratsimandresy, Yolande Vuo Masembe, Christiane Ramonjisoa Bodohanta, Isidore Koffi Kouadio, Issa Kana Kode Nyazy, Moussa Simpore, Charlotte Faty Ndiaye, Joseph Chukwudi Okeibunor
{"title":"Efforts Towards Polio Eradication in Madagascar: 1997 to 2017.","authors":"Marcellin Mengouo Nimpa,&nbsp;Noёline Ravelomanana Razafiarivao,&nbsp;Annick Robinson,&nbsp;Mamy Randriatsarafara Fidiniaina,&nbsp;Richter Razafindratsimandresy,&nbsp;Yolande Vuo Masembe,&nbsp;Christiane Ramonjisoa Bodohanta,&nbsp;Isidore Koffi Kouadio,&nbsp;Issa Kana Kode Nyazy,&nbsp;Moussa Simpore,&nbsp;Charlotte Faty Ndiaye,&nbsp;Joseph Chukwudi Okeibunor","doi":"10.29245/2578-3009/2021/S2.1102","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>In 1988, the World Health Assembly launched the Global Polio Eradication Initiative. WHO AFRO is close to achieve this goal with the last wild poliovirus detected in 2014 in Borno States in Nigeria. The certification of the WHO African Region requires that all the 47 member states meet the critical indicators for a polio free status. Madagascar started implementing polio eradication activities in 1996 and was declared polio free in June 2018 in Abuja. This study describes the progress achieved towards polio eradication activities in Madagascar from 1977-2017 and highlights the remaining challenges to be addressed.</p><p><strong>Methods: </strong>Data were collected from the national routine immunization services, Country Acute Flaccid surveillance databases and national reports of SIAS and Mop Up campaign. Country complete polio and immunization related documentation provided detailed historical information's.</p><p><strong>Results: </strong>From 1997 to 2017, Madagascar reported one wild poliovirus (WPV) outbreak and four circulating Vaccine Derived Polio Virus (cVDPV) oubreaks with a total of 21 polioviruses (1 WPV and 21 cVDPV). The last WPV and cVDPV were notified in 1997 in Antananarivo and 2015 in Sakaraha health districts respectively. Madagascar met the main polio surveillance indicators over the last ten years and made significant progress following the last cVDPV2 outbreak in 2014 -2015. In addition, the country successfully implemented the switch from trivalent Oral Polio Vaccine (tOPV) to bivalent Oral Polio vaccine (bOPV) and containment activities. Environmental Surveillance established since 2015 did not reveal any poliovirus. The administrative coverage of the 3rd dose of oral polio vaccine (OPV3) varied across the years from 55% in 1991 to a maximum of 95% in 2007 before a progressive decrease to 86% in 2017. The percentage of AFP cases with more than 3 doses of oral polio vaccines increased from 56% in 2014 to 88% in 2017. A total of 19 supplementary immunization activities (SIA) were conducted in Madagascar from 1997 to 2017, among which 3 were subnational immunization days (sNID) and 16 were national immunization days (NIDs). Poor routine coverage contributed to the occurrence of cVDPC outbreaks in the country; addressing this should remain a key priority for the country to maintain the polio free status.From 2015 to June 2017, Madagascar achieved the required criteria leading to the acceptance of the country's polio-free documentation in June 2018 by ARCC. However, continuous efforts will be needed to maintain a highly sensitive polio surveillance system with emphasis on security compromised areas. Finally strengthening the health system and governance at all levels will be necessary if these achievements are to be sustained.</p><p><strong>Conclusions: </strong>High national political commitment and support of the Global Polio Eradication Partnership were critical for Madagascar to achieve polio free status. Socio-political instability, weakness of the health system, sub-optimal routine immunization performance, insufficient SIA quality and existing security compromised areas remain critical program challenges to address in order to maintaining the polio free status. Continuous high-level advocacy should be kept in order to ensure that new government authorities maintain polio eradication among the top priorities of the country.</p>","PeriodicalId":73785,"journal":{"name":"Journal of immunological sciences","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2021-04-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7610765/pdf/","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of immunological sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.29245/2578-3009/2021/S2.1102","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 2

Abstract

Background: In 1988, the World Health Assembly launched the Global Polio Eradication Initiative. WHO AFRO is close to achieve this goal with the last wild poliovirus detected in 2014 in Borno States in Nigeria. The certification of the WHO African Region requires that all the 47 member states meet the critical indicators for a polio free status. Madagascar started implementing polio eradication activities in 1996 and was declared polio free in June 2018 in Abuja. This study describes the progress achieved towards polio eradication activities in Madagascar from 1977-2017 and highlights the remaining challenges to be addressed.

Methods: Data were collected from the national routine immunization services, Country Acute Flaccid surveillance databases and national reports of SIAS and Mop Up campaign. Country complete polio and immunization related documentation provided detailed historical information's.

Results: From 1997 to 2017, Madagascar reported one wild poliovirus (WPV) outbreak and four circulating Vaccine Derived Polio Virus (cVDPV) oubreaks with a total of 21 polioviruses (1 WPV and 21 cVDPV). The last WPV and cVDPV were notified in 1997 in Antananarivo and 2015 in Sakaraha health districts respectively. Madagascar met the main polio surveillance indicators over the last ten years and made significant progress following the last cVDPV2 outbreak in 2014 -2015. In addition, the country successfully implemented the switch from trivalent Oral Polio Vaccine (tOPV) to bivalent Oral Polio vaccine (bOPV) and containment activities. Environmental Surveillance established since 2015 did not reveal any poliovirus. The administrative coverage of the 3rd dose of oral polio vaccine (OPV3) varied across the years from 55% in 1991 to a maximum of 95% in 2007 before a progressive decrease to 86% in 2017. The percentage of AFP cases with more than 3 doses of oral polio vaccines increased from 56% in 2014 to 88% in 2017. A total of 19 supplementary immunization activities (SIA) were conducted in Madagascar from 1997 to 2017, among which 3 were subnational immunization days (sNID) and 16 were national immunization days (NIDs). Poor routine coverage contributed to the occurrence of cVDPC outbreaks in the country; addressing this should remain a key priority for the country to maintain the polio free status.From 2015 to June 2017, Madagascar achieved the required criteria leading to the acceptance of the country's polio-free documentation in June 2018 by ARCC. However, continuous efforts will be needed to maintain a highly sensitive polio surveillance system with emphasis on security compromised areas. Finally strengthening the health system and governance at all levels will be necessary if these achievements are to be sustained.

Conclusions: High national political commitment and support of the Global Polio Eradication Partnership were critical for Madagascar to achieve polio free status. Socio-political instability, weakness of the health system, sub-optimal routine immunization performance, insufficient SIA quality and existing security compromised areas remain critical program challenges to address in order to maintaining the polio free status. Continuous high-level advocacy should be kept in order to ensure that new government authorities maintain polio eradication among the top priorities of the country.

Abstract Image

Abstract Image

Abstract Image

马达加斯加根除脊髓灰质炎的努力:1997年至2017年。
背景:1988年,世界卫生大会发起了全球根除脊髓灰质炎倡议。世卫组织非洲办事处已接近实现这一目标,2014年在尼日利亚博尔诺州发现了最后一种野生脊髓灰质炎病毒。世卫组织非洲区域的认证要求所有47个会员国达到无脊髓灰质炎地位的关键指标。马达加斯加于1996年开始实施消灭脊髓灰质炎活动,并于2018年6月在阿布贾宣布消灭脊髓灰质炎。本研究描述了1977-2017年马达加斯加在消灭脊髓灰质炎活动方面取得的进展,并强调了仍需解决的挑战。方法:收集国家常规免疫服务机构、国家急性弛缓症监测数据库和国家SIAS和百日咳运动报告的数据。国家完整的脊髓灰质炎和免疫相关文件提供了详细的历史信息。结果:1997 - 2017年,马达加斯加共报告1次野生脊髓灰质炎病毒(WPV)暴发和4次循环疫苗衍生脊髓灰质炎病毒(cVDPV)暴发,共发生21种脊髓灰质炎病毒(1种WPV和21种cVDPV)。最后一次通报的野生脊灰病毒和cVDPV分别于1997年在塔那那利佛和2015年在萨卡拉哈卫生区发生。马达加斯加在过去十年中达到了主要的脊髓灰质炎监测指标,并在2014 -2015年最后一次cVDPV2疫情之后取得了重大进展。此外,该国成功地实施了从三价口服脊髓灰质炎疫苗(tOPV)到二价口服脊髓灰质炎疫苗(bOPV)的转变,并开展了遏制活动。自2015年以来建立的环境监测未发现任何脊髓灰质炎病毒。第三剂口服脊髓灰质炎疫苗(OPV3)的行政覆盖率逐年变化,从1991年的55%到2007年的最高95%,然后逐步下降到2017年的86%。接种3剂以上口服脊髓灰质炎疫苗的AFP病例百分比从2014年的56%增加到2017年的88%。1997 - 2017年,马达加斯加共开展了19次补充免疫活动(SIA),其中3次为次国家免疫日(sNID), 16次为国家免疫日(NIDs)。常规覆盖率低导致该国暴发了cVDPC疫情;解决这一问题仍应是该国保持无脊髓灰质炎状态的关键优先事项。从2015年到2017年6月,马达加斯加达到了所需的标准,导致ARCC于2018年6月接受了该国的无脊髓灰质炎文件。然而,需要继续努力维持高度敏感的脊髓灰质炎监测系统,重点放在安全受损地区。最后,如果要维持这些成就,就必须加强各级卫生系统和治理。结论:高度的国家政治承诺和对全球根除脊髓灰质炎伙伴关系的支持对马达加斯加实现无脊髓灰质炎地位至关重要。社会政治不稳定、卫生系统薄弱、常规免疫绩效不理想、免疫补充质量不足和现有安全受损领域仍然是规划要解决的关键挑战,以便维持无脊髓灰质炎状态。应继续进行高级别宣传,以确保新政府当局将消灭脊髓灰质炎作为该国的首要优先事项之一。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信